1. Yabroff KR, Warren JL, Brown ML. Costs of cancer care in the USA: adescriptive review. Nat Clin Pract Oncol. 2007; 4:643–56.
2. Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst. 2011; 103:117–28.
Article
3. Statistics Korea. Annual report on the cause of death statistics. Daejeon: Korea National Statistical Office;2007.
4. National Cancer Center, Ministry of Health and Welfare. Cancer facts and figures 2013 in the Republic of Korea. Goyang: National Cancer Center;2013.
5. Yabroff KR, Lund J, Kepka D, Mariotto A. Economic burden of cancer in the United States: estimates, projections, and future research. Cancer Epidemiol Biomarkers Prev. 2011; 20:2006–14.
Article
6. Chastek B, Harley C, Kallich J, Newcomer L, Paoli CJ, Teitelbaum AH. Healthcare costs for patients with cancer at the end of life. J Oncol Pract. 2012; 8:75s–80s.
7. Hogan C, Lunney J, Gabel J, Lynn J. Medicare beneficiaries’ costs of care in the last year of life. Health Aff (Millwood). 2001; 20:188–95.
Article
8. Yi JJ, Yoo WK, Kim SY, Kim KK, Yi SW. Medical expenses by site of cancer and survival time among cancer patients in the last one year of life. J Prev Med Public Health. 2005; 38:9–15.
9. Choo SY, Lee SY, Kim CW, Kim SY, Yoon TH, Shin HR, et al. Educational differences in health care utilization in the last year of life among South Korean cancer patients. J Prev Med Public Health. 2007; 40:36–44.
Article
10. Choi KS, You CH, Lee KH, Kim CY, Heo DS, Yun YH. Comparison of medical care cost between hospice care and conventional care in the last year of life. Korean J Health Policy Adm. 2005; 15:1–15.
11. Yoon TH, Lee SY, Kim CW, Kim SY, Jeong BG, Park HK. In equalities in medical care utilization by South Korean cancer patients according to income: a retrospective cohort study. Int J Health Serv. 2011; 41:51–66.
12. Dinan MA, Curtis LH, Hammill BG, Patz EF Jr, Abernethy AP, Shea AM, et al. Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999-2006. JAMA. 2010; 303:1625–31.
Article
13. Jung KW, Park S, Kong HJ, Won YJ, Lee JY, Seo HG, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2009. Cancer Res Treat. 2012; 44:11–24.
Article
14. Kim SY, Park JH, Kim SG, Woo HK, Park JH, Kim Y, et al. Disparities in utilization of high-volume hospitals for cancer surgery: results of a Korean population-based study. Ann Surg Oncol. 2010; 17:2806–15.
Article
16. Brown ML, Lipscomb J, Snyder C. The burden of illness of cancer: economic costand quality of life. Annu Rev Public Health. 2001; 22:91–113.
17. Yabroff KR, Mariotto AB, Feuer E, Brown ML. Projections of the costs associated with colorectal cancer care in the United States, 2000-2020. Health Econ. 2008; 17:947–59.
Article
18. Athas WF, Adams-Cameron M, Hunt WC, Amir-Fazli A, Key CR. Travel distance to radiation therapy and receipt of radiotherapy following breast-conserving surgery. J Natl Cancer Inst. 2000; 92:269–71.
Article
19. Kim SG, Park WS. Out-of-pocket health expenditures among adult Koreans with cancer. Korean J Med. 2006; 70:61–8.
20. Keam B, Oh DY, Lee SH, Kim DW, Kim MR, Im SA, et al. Aggressiveness of cancer-care near the end-of-life in Korea. Jpn J Clin Oncol. 2008; 38:381–6.
Article
21. Fawzy FI. Psychosocial interventions for patients with cancer: what works and what doesn’t. Eur J Cancer. 1999; 35:1559–64.
22. Yoshioka H. Rehabilitation for the terminal cancer patient. Am J Phys Med Rehabil. 1994; 73:199–206.
23. Sharp L, Timmons A. The financial impact of a cancer diagnosis. Cork, IR: Irish Cancer Society;2010.
24. Yang Y, Czernin J. Contribution of imaging to cancer care costs. J Nucl Med. 2011; 52 Suppl 2:86S–92S.
Article
25. Brown ML, Riley GF, Schussler N, Etzioni R. Estimating health care costs related to cancer treatment from SEER-Medicare data. Med Care. 2002; 40(8 Suppl):IV-104–17.
Article